<DOC>
	<DOC>NCT00044343</DOC>
	<brief_summary>The purpose of this study is to determine the efficacy of an oral investigational drug in patients with refractory metastatic colorectal cancer after receiving prior therapy with 5-fluorouracil in combination with irinotecan and/or oxaliplatin.</brief_summary>
	<brief_title>GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Lapatinib</mesh_term>
	<criteria>Provide signed informed consent. Refractory Stage IV metastatic colorectal cancer. Received at least 2 cycles of firstline therapy with intravenous 5FU (5fluorouracil) in combination with CPT11 (irinotecan) and/or oxaliplatin. No more than one prior therapy. Tumor tissue available for testing. 4 weeks since firstline cancer regimen. Able to swallow and retain oral medication. Cardiac ejection fraction within the institutional range of normal as measured by MUGA (Multiple Gated Acquisition Scan). Adequate kidney and liver function. Adequate bone marrow function. Pregnant or lactating female. Conditions that would affect absorption of an oral drug Firstline regimen did not include 5fluorouracil with irinotecan and/or oxaliplatin. Serious medical or psychiatric disorder that would interfere with the patient''s safety or informed consent. Severe cardiovascular disease or cardiac (heart) disease requiring a device. Active infection. Brain metastases. Concurrent cancer therapy or investigational therapy. Use of oral or intravenous steroids. Unresolved or unstable, serious toxicity from prior therapy. Prior therapy with an EGFR (Endothelial Growth Factor Receptor) and/or erbB2 inhibitor.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>colorectal cancer</keyword>
	<keyword>EGFR inhibitor</keyword>
	<keyword>lapatinib</keyword>
	<keyword>metastatic</keyword>
</DOC>